Vagus Nerve Stimulation trials

Investigation to Understand and Optimize Psilocybin

RecruitingNCT06512194Phase: PHASE2Started 2025-05-13

Summary

This study will examine the effects of a single dose of psilocybin, administered with psychological support, on symptoms of depression. It will also assess whether different post-dosing interventions,

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
70 Years

Locations

Vail Health Behavioral HealthEdwards, Colorado, United States

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT06512194